ITI Pharma and Healthcare Fund
In plain words
as of 20 Nov 2026Over 5 years it returned 15.7% a year, above the middle Sectoral / Thematic fund (13.4%) by 2.3 points.
Trailed its benchmark by 1.1 points a year over 5 years (15.7% vs 16.9%).
Its ups and downs have been about typical for its category. Volatility 15.9% vs a category middle of 17.4%.
The deepest fall was −17.7% (Jan 2022 to Jun 2022); it recovered in 364 days.
Of every 1-year period since launch, 22% ended below where they started. The middle 1-year result was 15.6%.
Key facts
- Fund house
- ITI Mutual Fund
- Category
- Sectoral / Thematic (SEBI)
- Plan & option
- Direct · Growth
- Benchmark i
- NIFTY Pharma TRI (tracked via Nippon India Nifty Pharma ETF - Direct Plan)
- First NAV
- 11 Nov 2021 · 5.0 years of history · 1,237 NAVs
- AMFI code
- 149268
- ISIN
- INF00XX01BO9
- Expense ratio i
- 0.86%
- Fund size
- Not loaded yet
How ₹100 grew
Returns
Up to 1 year: total change. Longer: yearly (CAGR) i| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch | |
|---|---|---|---|---|---|---|---|---|---|---|
| This fund | +11.35% | +4.42% | +12.33% | +21.31% | +18.01% | +19.94% | +15.73% | — | — | +15.56% |
| NIFTY Pharma TRI* | +10.85% | +7.49% | +14.67% | +25.66% | +25.86% | +22.31% | +16.87% | — | — | — |
| Sectoral / Thematic middle fund i | +7.06% | +0.76% | +8.56% | +4.78% | +4.51% | +14.52% | +13.44% | +17.70% | +15.67% | — |
Category middle = median Direct Growth fund in Sectoral / Thematic (145 funds with 3 years). * Benchmark approximated by Nippon India Nifty Pharma ETF - Direct Plan with its expense ratio added back. Blank means not enough history, never zero.
Risk and risk-adjusted return
Last 36 months · risk-free rate 6.5%Against its benchmark
NIFTY Pharma TRI · 36 monthly returnsThe worst it has been
Every 1-year period i
One 5-year number depends on its start date. These show what happened across every start date in the fund's life.
What it holds
Against similar funds
Top Sectoral / Thematic Direct Growth funds by return. A sort by one past number, not a recommendation.
| Fund | Return | Volatility | Sharpe | Alpha | Beta | Deepest fall | Stars |
|---|---|---|---|---|---|---|---|
| HDFC Defence Fund HDFC | +31.36% | 30.9% | 0.80 | — | — | −34.54% | ★★★★★ |
| Nippon India Taiwan Equity Fund Nippon India | +31.07% | 42.4% | 0.58 | +30.87% | −0.14 | −47.10% | ★★★★★ |
| HDFC Pharma and Healthcare Fund HDFC | +30.70% | 15.8% | 1.53 | +7.54% | 0.97 | −14.91% | ★★★★★ |
| SBI HEALTHCARE OPPORTUNITIES FUND SBI | +24.78% | 14.1% | 1.30 | +5.20% | 0.86 | −30.53% | ★★★★★ |
| HDFC Transportation and Logistics Fund HDFC | +24.43% | 19.1% | 0.94 | +11.22% | 1.02 | −23.50% | ★★★★★ |
| Mirae Asset Healthcare Fund Mirae Asset | +24.02% | 15.5% | 1.13 | +3.31% | 0.96 | −19.98% | ★★★★★ |
| UTI - Healthcare Fund UTI | +23.24% | 15.4% | 1.09 | +3.12% | 0.91 | −27.10% | ★★★★★ |
| Aditya Birla Sun Life Transportation and Logistics Fund ABSL | +23.16% | 19.9% | 0.84 | +9.65% | 1.09 | −28.25% | Not rated |
| ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND ICICI Pru | +22.67% | 18.9% | 0.86 | +9.34% | 1.06 | −23.58% | ★★★★★ |
| LIC MF Healthcare Fund LIC | +21.83% | 15.5% | 0.99 | +2.28% | 0.90 | −15.10% | ★★★★★ |
| ITI Pharma and Healthcare Fund ITI | +19.94% | 15.9% | 0.85 | −1.30% | 0.98 | −17.69% | ★★★★★ |
Compare side by side with another Sectoral / Thematic fund
All plans and options
| Scheme | NAV | AMFI code |
|---|---|---|
| Direct · Growth | ₹20.7004 | 149268 |
| Direct · IDCW | ₹20.6981 | 149271 |
| Regular · Growth | ₹18.7412 | 149270 |
| Regular · IDCW | ₹18.7412 | 149269 |
About Sectoral / Thematic funds
- The rule
- At least 80% in one sector (banking, pharma, IT ...) or theme (consumption, manufacturing ...).
- Who it can suit
- Investors adding a deliberate bet on top of a diversified core.
- Typical holding period
- 7 years or more
Questions people ask
What is the NAV of ITI Pharma and Healthcare Fund?
₹20.7004 as of 20 Nov 2026, from AMFI's daily NAV file. NAVs are published once every business day after markets close.
Direct or Regular: what is the difference?
Same portfolio. Regular pays a distributor commission inside its fee, so it returns a little less every year.
Growth or IDCW?
Growth reinvests everything. IDCW pays some out, so its NAV drops after each payout and its NAV-based return understates what investors received.
How are these numbers calculated?
Every figure is computed by Growth from the fund's published NAV history. See How we calculate.